)
)
Avid Bioservices Investor Relations Material
Latest events
Q1 2025
Avid Bioservices
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Avid Bioservices Inc
Access all reports
Avid Bioservices, Inc. is a contract development and manufacturing organization (CDMO) providing quality controlled clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. Avid’s full range of services include process development, validation and delivery, master cell banking, equipment maintenance, packaging development, stability studies as well as after-market and manufacturing site support for biologics in development.
Latest articles
)
Cristiano Amon: Qualcomm's 5G Specialist CEO
Cristiano Amon, Qualcomm CEO, has spent two decades at the company while taking on several roles, developing both technical and business expertise.
16 Sep 2024
)
Qualcomm: Quality Communication and Semiconductor Innovation
Founded in 1985, Qualcomm has transformed the digital communication industry with CDMA technology and its advanced semiconductor business.
13 Sep 2024
)
Strong Opinions, Loosely Held: Pontus Dackmo on Flexibility and Market Psychology
After a two-decade career in finance, Pontus Dackmo co-founded Protean Funds Scandinavia in 2022, where he now serves as CEO and Investment Manager.
4 Sep 2024
Ticker symbol
CDMO
Country
🇺🇸 United States